Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects

Thorax

Volumn 58, Issue 3, 2003, Pages 258-260

  Harrison, T W ^a   Tattersfield, A E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; POWDER INHALER; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT;

ADMINISTRATION, INHALATION; ANDROSTADIENES; AREA UNDER CURVE; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; POWDERS;

EID: 0037340272     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.3.258     Document Type: Article

References (10)

1. Wong CA, Walsh LJ, Smith CJP, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000;355:1399-403.
2. Brutsche MH, Brutsche IC, Munavvar M, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000;356:556-61.
3. Harrison TW, Wisniewski A, Honour J, et al. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler between healthy and asthmatic subjects. Thorax 2001;56:186-91.
4. Mollman H, Wagner M, Meibohm B, et al: Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol 1998;53:459-67.
5. Bisgaard H, Klug B, Sumby BS, et al. Fine particle mas from the Diskus inhaler and turbuhaler in children with asthma. Eur Respir J 1998;11:1111-5.
6. Melchor R, Biddiscombe MF, Mak VHF, et al. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993;48:506-11.
7. Boorsma M, Andersson N, Larsson P, et al. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996;9:1427-32.
8. Donnelly R, Williams KM, Baker AB, et al. Effects of budesonide and fluticasone on 24 hour plasma cortisol. Am J Respir Crit Care Med 1997;156:1746-51.
9. Nielson LP, Dahl R. Therapeutic ratio of inhaled corticosteroids in adult asthma: a dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir Crit Care Med 2000;162:2053-7.
10. Martin RJ, Szefler SS, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002;165:1377-83.